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characterization of diploid human fibroblasts derived from
fetal tissues. Their study results demonstrated unequivo-
cally that cells in culture had a finite number of subculti-
vations (also referred to as cell passage) of approximately
50 before achieving growth arrest. These findings were
not caused by medium components or culture conditions,
but instead were an inherent property of the cells them-
selves in culture. This phenomenon was interpreted as
aging at the cell level, therefore refuting the concept of
cell immortality, and was established as an in vitro model
for which exhaustion of the doubling capacity in human
diploid fibroblasts is recognized as cellular senescence. In
the last 35 years, many cell types from various animal
species have been studied and shown to have a finite
replicative life span. By definition, postmitotic cells, which
do not replicate, do not undergo cellular senescence.
Instead, cellular senescence affects the phenotype of divid-
ing cells only.
In the last decade, the model of cellular senescence has
been applied in vitro to human cells comprising living tis-
sues, with the implication of possibly having an important
role in the function of tissue integrity. The role of cellular
senescence has been extended to explain the aging
process, tumor suppression, and impaired tissue function
resulting in poor wound healing. In the aforementioned
normal process of aging and disease states related to neo-
plastic transformation and wound impairment, it is worth-
while to review the expected replicative capacity of cells as
they undergo sequential population doublings. As seen in
Fig 1, the proliferative capacity of the cells decreases with
increasing population doublings. As fibroblasts approach
senescence, each cell at a given passage will have under-
gone a finite number of divisions, and the population of
fibroblasts as a whole will be at varying stages toward
senescence, depending on the number of population dou-
blings. The entire population of fibroblasts can be said to
have reached cellular senescence when every cell in the
culture has completed its replicative life span. At this stage,
growth arrest is irreversible, and a senescent cell cannot be
stimulated by any physiologic mitogens to initiate DNA
replication.
MOLECULAR CHARACTERISTICS 
OF CELLULAR SENESCENCE
The hallmark of cellular senescence is the irreversible
In this review of basic vascular science, the two cellu-
lar events consisting of cellular senescence and apoptosis
are defined, and their molecular properties are elucidated.
We emphasize that these are two unique cellular functions
and should not be used interchangeably. Their importance
in vascular biology is only recently beginning to be real-
ized, and they may have potential mechanistic implications
in providing a better understanding of arterial and venous
diseases. Cellular senescence has been shown to be a char-
acteristic in venous ulcer fibroblast grown in culture and a
marker of endothelial cells found in diseased arteries.
Likewise, apoptosis is responsible for cell turnover and cel-
lular environment homeostasis and appears to be altered in
diseased arterial and venous tissues, and it is possibly a
contributing factor in the pathophysiology of atheroscle-
rosis. In addition, the difference between apoptosis and
cell necrosis will be highlighted.
CELLUAR SENESCENCE
The hallmark of cellular or replicative senescence is an
irreversible arrest of cell proliferation with maintenance of
cell functions. At the turn of the 20th century, Alexis
Carrel, a distinguished Nobel laureate, surgeon, and cell
culturist, demonstrated that fibroblasts from the chick
heart were immortal in tissue culture. Because of this find-
ing and the duplication of these results by other laborato-
ries, the prevailing dogma until the 1960s was the belief
that all cultured cells were immortal. Because it was rec-
ognized that on occasion and at exceedingly low frequen-
cies immortal cells can arise spontaneously from normal
cell cultures and that external stimuli such as carcinogens,
radiation, and oncogenic viruses are required for cell
transformation and immortality, the hypothesis of Carrel
was challenged. In 1961, the extensive tissue culture stud-
ies of Hayflick and Moorhead described the isolation and
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growth arrest of the cell, with preservation of metabolic
function. Morphologically, senescent cells are larger in size
and can have polygonal shapes. This appearance may be
caused in part by a number of growth regulatory depen-
dent genes being repressed. Although these aspects are the
primary characteristics of a senescent cell, the molecular
events involving alterations in signal transduction and the
regulation of DNA replication are fundamental in distin-
guishing senescent cells from replicating cells and cells
undergoing apoptosis. Fig 2 is a schematic representation
of a senescent cell, demonstrating the effect of physiologic
mitogens or environmental stimuli on the molecular path-
ways involving the interaction of cell receptors, secondary
messenger moieties, and regulatory proteins leading to the
inhibition of DNA replication. The loss of proliferative
capacity in senescent cells is partially explained by the pro-
found attenuated response to growth factors, such as basic
fibroblast growth factor, epidermal growth factor, trans-
forming growth factor, and platelet-derived growth factor.
Studies in normal human diploid fibroblasts from the WI-
38 cell line have demonstrated that the ligand-receptor
binding, receptor density (number of receptors per cell
surface area), and the affinity of the receptor for the ligand
are unchanged in early passage (presenescent) versus late
passage (senescent) fibroblasts. The mechanism for the
attenuated response of the cell receptor to the mitogenic
stimuli appears to be a function of both alterations in the
receptor structural moiety and in the postreceptor sec-
ondary messenger pathways. The changes in secondary
messenger signal transduction involve different molecules
consisting of phospholipid metabolite arachidonic acid
and the production of prostaglandins, diacylglycerol, pro-
tein kinase A and C, cyclic adenosine monophosphate, and
intracellular calcium.
There are a number of normally expressed genes in the
cell cycle that are not expressed in senescent cells. These
genes, such as cyclin A, proliferating cell nuclear antigen,
thymidine kinase, and DNA polymerase α, are regulated
by the transcription factor E2F. The inability of senescent
cells to synthesize and replicate DNA during the cell cycle
involves in part the suppression of at least three positive-
acting genes. In senescent fibroblasts, the expression of 
c-fos proto-oncogene, helix-loop-helix id-1 and id-2
genes, and the components of the E2F transcriptional 
factor is inhibited, triggering the inability of the cell for
DNA synthesis. The alterations of the growth-regulating
genes in senescent fibroblasts are intimately coupled to
various cell-cycle dependent proteins. The expression of
cell-cycle regulator proteins tumor suppressor p53, cyclin-
dependent kinase inhibitor p21 (cip1/sdi1/waf1) and
p16 (cdkn2/ink4a), and the tumor suppressor retinoblas-
toma susceptibility protein pRb is involved directly or
indirectly in the regulation of cell proliferation. The over-
expression of p21 is an important regulator of cell prolif-
eration in senescent cells. Because p21 (and also p16)
inhibits cyclin-dependent protein kinases, which leads to
the constitutive underphosphorylation of pRb and E2F
suppression, this protein plays a major role in inhibiting
cell proliferation in senescent cells. It is suggested by evi-
dence that inactivation of p21 by genetic modulation can
bypass the events of senescence in human diploid fibro-
blasts and that oncogenic ras (a proliferation cell-regulat-
ing protein) can lead to accumulation of p16 and p53,
leading to premature cellular senescence.
Senescent cells display altered differentiated functions,
which can impart changes on the extracellular environ-
ment. Senescent cells display resistance to apoptosis prob-
ably through the overexpression of Bcl-2 protein. Because
senescent cells would resist programmed cell death, invari-
ably this would lead to the accumulation of these cells
within tissues. The accumulation of senescent cells in vivo
that have achieved growth arrest has been postulated to
have consequences affecting aging, neoplastic differentia-
tion, and impaired tissue integrity and healing. A recent
senescent marker called senescent-associated β galactosi-
dase (SA β-gal) persists in aged tissues and increases with
increasing population doublings. SA β-gal staining of cul-
tured human fibroblasts, which is a marker for cellular
senescence, results in a perinuclear blue staining that char-
acterizes these fibroblasts as senescent. Further changes in
senescent cells involve the overproduction of matrix me-
talloproteinases, collagenases, and gelatinases and de-
creased amounts of metalloproteinase inhibitors. The
imbalance of elevated proteinase activity compared with
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Fig 1. Replicative capacity of normal somatic mammalian cells
undergoing sequential population doublings (PD; 1PD = popula-
tion of cells that has doubled in number). Replicative capacity
depends on type, age, environmental influences (eg, viruses), and
pathologic state of cells. During normal proliferative capacity (eg,
newborn fibroblasts, adult dermal fibroblasts), cells undergo
many population doublings before replicative exhaustion (A).
Fibroblasts cultured from tissue with concomitant pathology (eg,
venous ulcers) have reduced growth potential and are at a higher
stage toward reaching cellular senescence than normal fibroblast
(B). At the end of life span of cell, proliferative capacity has been
exhausted, and cells are senescent (C). Cells that have completed
their PDs can escape cellular senescence and become immortal
either spontaneously (rare) or be transformed by viruses to con-
tinue to replicate and extend their normal PDs (D).
antiproteinase has been implicated not only in the degra-
dation of important extracellular structural proteins like
fibronectin, but also in degrading growth factors and their
receptors. It appears that the accumulation of senescent
cells in tissues can have profound effects on neighboring
cells and ultimately on the normal aging process and in
disease states.
APOPTOSIS
Apoptosis, a word derived from the Greek word
“falling leaves,” is defined as a programmed cell death.
Apoptosis has recently received a lot of attention in medi-
cine and science because of its importance during organ-
ism development, pathogenesis, and cell transformation.
Apoptosis is a fundamental biologic process required to
maintain the integrity and homeostasis of a multicellular
organism. The etiology of many intractable human dis-
eases, including neurodegenerative disorders such as
Alzheimer’s and Parkinson’s diseases and cancer, is associ-
ated with alterations in cell apoptosis. Furthermore, apop-
tosis is implicated in the progression of cell death during
JOURNAL OF VASCULAR SURGERY
Volume 34, Number 1 Raffetto et al 175
reperfusion injury of ischemic tissue and in brain and
myocardial tissues at risk from further insult during a
stroke and myocardial infarction, respectively.
Apoptosis should be distinguished from necrosis.
Necrotic cell death is pathologic and results from acute
cellular injury, leading to rapid cellular edema and lysis. In
contrast, cell death by apoptosis has the hallmark of con-
trolled autodigestion of the cell. This process leads to the
formation of apoptotic bodies within the intact cell plasma
membrane. Unlike cellular necrosis, which is accompanied
by an inflammatory response because of the loss of mem-
brane integrity, an important feature of apoptosis is that
elimination of apoptotic cells by mononuclear cell phago-
cytosis occurs without the induction of an inflammatory
response. Apoptosis occurs when cells commit suicide in
response to exogenous stimuli or intrinsic signals to main-
tain homeostasis of the organism. The events that commit
a cell to either a path of apoptosis or necrotic cell death
after a specific stimulus are dictated in the former and not
the latter by the activation of the central cell death signal
either through a specific set of surface death receptors or
Fig 2. Signaling pathways leading to cellular senescence and DNA inhibition. Various ligands, hormones,
and cytokines (M2, M3) bind to cell surface receptors (R2 , R3), or growth factors (M1) bind to specific
growth factor receptor (GF R1). Signal transduction to initiate DNA replication involves various mem-
brane-associated proteins, adenylate cyclase (AC), tyrosine protein kinase (TPK), G protein (GP), phos-
pholipase C (PLC), and protein kinase C (PKC). Phosphotidylinositol-4,5-biphosphate (PIP2) is the
substrate for PLC to form secondary messengers inositol triphosphate (IP3) and diacylglycerol (DAG). In
turn, DAG is important in activating PKC by membrane translocation. Senescent cells have attenuated
response to signal transduction (double bars), leading to inhibition of DNA synthesis. Arrest of DNA syn-
thesis is also a result of increased metabolites of phospholipids (PL) by action of phospholipase A2 (PLA2)
to produce elevated levels of arachidonic acid (AA) and prostaglandin E2 (PGE2) and by inhibition of
cyclin-dependent protein kinases (CDK) by overexpression of p21 and p16, causing underphosphoryla-
tion of pRb (ie, decrease pRb-PO4) and consequently inhibition of gene expression necessary for DNA
replication. DHFR, Dihydrofolate reductase; TK, thymidine kinase; DNA poly α, DNA polymerase alpha;
PCNA, cofactor proliferating cell nuclear antigen.
directly within the cell by drugs, toxins, or radiation (Fig
3). The signals for apoptosis induction can be intrinsic or
extrinsic. There are many inducers of apoptosis, such as
physiologic activators (tumor necrosis factor [TNF], neu-
rotransmitters, growth factor withdrawal), oxygen reactive
metabolites, viral infection, chemotherapeutic drugs, radi-
ation (UV and gamma), and toxins. These stimuli can
direct their effect by activating specific death receptors,
causing perturbations of the cell membrane or metabolic
functions, or by causing direct DNA damage. Once a cell
has been induced to go through apoptosis, a cascade of
events occurs. The first event is provocation of the apop-
totic response. For activation of the cell surface receptors,
ligands, which are structurally related to the TNF gene
superfamily (with the exception of nerve growth factor),
bind and stimulate a complex family of death receptors
that also belong to the TNF gene superfamily. These
death receptors share a similarity in possessing a cysteine-
rich extracellular domain and a cytoplasmic homologous
sequence named the death domain. There are a number of
death receptors that have been characterized, such as TNF
receptor family, nerve growth factor receptor, CD95
receptor (also called Fas or Apo1), death receptor 3 (also
called DR3, Apo3, LARD, or TRAMP), and DR5 (also
called Apo2, TRAIL-R2, TRICK 2, or KILLER). After
the activation of the death receptors by the specific stim-
uli, a central cell death signal is transduced, triggering
apoptosis by activation of a group of cysteine proteases.
These proteases are called caspases (cysteinyl aspartate-
specific proteinases), which are inactive precursor polypep-
tides, and in turn are cleaved at specific aspartate residues
and assembled into active heterotetramer proteases that
ultimately begin to digest DNA in a defined and specific
fashion. One of the signature changes associated with
apoptosis is DNA fragmentation. Whereas necrosis-
induced death causes nonspecific degradation of chromo-
somal material, in programmed cell death specific sites of
DNA are rapidly restricted or cut such that it creates pre-
dictable DNA fragments measuring in multiples of 180
base pairs. In human physiology, apoptosis plays a very
important role. Cells that are constantly exposed to UV
radiation, such as skin cells, or cells that have a limited life
span tend to be resistant to apoptosis. Resistance to apop-
tosis for these cells is developed for long-term survival. In
contrast, immune cells are very susceptible to apoptosis.
This is a physiologic attempt to regulate autoantibody
production. Pathogenesis occurs when a cell type loses its
original susceptibility to apoptosis. When immune cells are
activated, they produce antibodies against foreign pro-
teins; however, as soon as antibodies are produced, apop-
tosis is induced, so that cells producing particular
antibodies are quickly destroyed. Apoptosis associated
with the vascular diseases is not well known, and this is an
area of research that could be further explored.
As described, the hallmark of cellular senescence is the
loss of proliferative capacity, whereas the hallmark of apop-
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Fig 3. Cellular events during apoptosis and necrosis. Extrinsic or intrinsic signals initiate a cascade of
events that will cause cell to undergo either apoptosis (specific DNA fragmentation) or necrosis (nonspe-
cific DNA degradation). Apoptosis involves activation of specific death receptors (R1, R2, and R3) or direct
DNA damage. A central death signal initiates cell death effector machinery, with activation of caspases with
DNA fragmentation ensuing. Bcl-2 protein blocks activation of caspases. Necrosis path of cell death
involves reduction of adenosine triphosphate (ATP) generation, leading to cellular edema from inhibition
of sodium-potassium adenosine triphosphatase (ATPase) pump (ATPase Na/K) and DNA degradation
and cell membrane rupture.
tosis is sequential cellular events that lead to programmed
cell death. These two events are not related and have dis-
tinctive biological pathways. Senescent cells are shown to
be resistant to apoptosis. However, resistance to apoptosis
does not equate with loss of proliferative capacity. Cells
such as keratinocytes, which are constantly exposed to UV
radiation, display a high degree of resistance to apoptosis.
Especially those keratinocytes thought to be stem cells are
protected from apoptosis, and they are resistant to apopto-
sis induced by UV radiation. However, by definition, stem
cells have a high proliferative capacity and, when required,
divide. Thus senescence and apoptosis are two distinctive
biological pathways, and each contributes separately to the
development and pathogenesis of an organism.
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